IP Library › Patent Application 14655251
Patent Application
App. No. 14/655,251

ADMINISTRATION OF RECOMBINANT COLLAGEN 7 FOR THE TREATMENT OF AGE RELATED DISORDERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/655,251
Abstract

The present disclosure provides methods of treating age related disorders through the administration of collagen 7 or the functional fragment or variant thereof

Claims (13)

1 . A method of treating a subject, the method comprising:

administering to an elderly subject having or at risk of having an age related disorder, collagen 7 or functional fragments and variants thereof.

2 . The method of claim 1 , wherein the age-related disorder is skin cancer.

3 . The method of claim 1 , wherein the age-related disorder is vaginal tearing.

4 . A method of treating a subject, the method comprising:

administering to an elderly or chronically ill subject who has had a skin lesion that has been surgically excised, collagen 7 or functional fragments and variants thereof.

5 . (canceled)

6 . A method of treating a subject, the method comprising:

selecting a subject diagnosed with a disorder in which the treatment of the disorder is an organ transplant, and

administering to the subject collagen 7 or functional fragments and variants thereof.

7 . The method of claim 3 , wherein vaginal tearing comprises tearing, abrasion, or erosion of the skin around the vagina.

8 . The method of claim 4 , wherein the skin lesion is a skin cancer.

9 . The method of claim 2 , wherein the subject has received an organ transplant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 043447/0805 →